Osteoporosis is the most common bone disease in adults and confers significant morbidity and mortality in women. Universal screening is recommended for women above the age of 65 years; however, screening rates remain low. Bisphosphonates are the treatment of choice despite a decline in their use due to concerns about rare side effects. Treatment of osteoporosis dramatically decreases the likelihood of fragility fractures. Copyright © 2022 Elsevier Inc. All rights reserved.
Vidya Gopinath. Osteoporosis. The Medical clinics of North America. 2023 Mar;107(2):213-225
PMID: 36759092
View Full Text